iSpecimen (ISPC) P/E (2021 - 2026)
iSpecimen (ISPC) P/E from Jun 30, 2021 to Jul 21, 2026. The TTM iSpecimen (ISPC) P/E is -3.83. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of iSpecimen (ISPC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.83 | -78.28% |
| 2025 | -17.64 | -40.77% |
| 2024 | -29.79 | -98.34% |
| 2023 | -1.80K | -63.59% |
| 2022 | -4.94K | -82.39% |
| 2021 | -28.08K | N/A |
Comparison iSpecimen (ISPC) P/E with competitors
iSpecimen (ISPC) P/E is -3.83.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -127.36% |
| MBAI | CheckCap Ltd | 1.71 | -144.69% |
| FONR | Fonar Corp | 15.48 | -503.88% |
| QGEN | Qiagen NV | 20.03 | -622.65% |
| DGX | Quest Diagnostics Inc | 22.47 | -686.41% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -722.88% |
| IQV | IQVIA Holdings Inc | 25.28 | -759.72% |
| A | Agilent Technologies Inc | 26.96 | -803.43% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -922.70% |
| MTD | Mettler-Toledo International Inc | 32.45 | -946.75% |
| MEDP | Medpace Holdings Inc | 32.55 | -949.35% |
| DHR | Danaher Corp | 38.55 | -1106.00% |
| IDXX | Idexx Laboratories Inc | 40.58 | -1158.76% |
| ILMN | Illumina Inc | 44.12 | -1251.24% |
| RVTY | Revvity Inc | 52.68 | -1474.64% |
| VCYT | Veracyte Inc | 53.71 | -1501.54% |
| ICLR | Icon Plc | 57.45 | -1599.11% |
| SHC | Sotera Health Company | 74.08 | -2033.13% |
| WAT | Waters Corp | 102.79 | -2782.06% |